ArticleAmerican journal of respiratory cell and molecular biology2014

Targeting interleukin-13 with tralokinumab attenuates lung fibrosis and epithelial damage in a humanized SCID idiopathic pulmonary fibrosis model.

Lynne A Murray et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.